• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰丝氨酸及其立体异构体的合成:它们在血液凝固激活中的作用。

Synthesis of Phosphatidylserine and Its Stereoisomers: Their Role in Activation of Blood Coagulation.

作者信息

Mallik Suman, Prasad Ramesh, Bhattacharya Anindita, Sen Prosenjit

机构信息

Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, India.

出版信息

ACS Med Chem Lett. 2018 Apr 12;9(5):434-439. doi: 10.1021/acsmedchemlett.8b00008. eCollection 2018 May 10.

DOI:10.1021/acsmedchemlett.8b00008
PMID:29795755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5949724/
Abstract

Natural phosphatidylserine (PS), which contains two chiral centers, enhances blood coagulation. However, the process by which PS enhanced blood coagulation is not completely understood. An efficient and flexible synthetic route has been developed to synthesize all of the possible stereoisomers of PS. In this study, we examined the role of PS chiral centers in modulating the activity of the tissue factor (TF)-factor VIIa coagulation initiation complex. Full length TF was relipidated with phosphatidylcholine, and the synthesized PS isomers were individually used to estimate the procoagulant activity of the TF-FVIIa complex via a FXa generation assay. The results revealed that the initiation complex activity was stereoselective and had increased sensitivity to the configuration of the PS glycerol backbone due to optimal protein-lipid interactions.

摘要

天然磷脂酰丝氨酸(PS)含有两个手性中心,可增强血液凝固。然而,PS增强血液凝固的过程尚未完全了解。现已开发出一种高效且灵活的合成路线来合成PS的所有可能立体异构体。在本研究中,我们研究了PS手性中心在调节组织因子(TF)-因子VIIa凝血起始复合物活性中的作用。全长TF用磷脂酰胆碱重新脂质化,合成的PS异构体分别用于通过FXa生成试验评估TF-FVIIa复合物的促凝血活性。结果表明,起始复合物活性具有立体选择性,并且由于最佳的蛋白质-脂质相互作用,对PS甘油主链的构型具有更高的敏感性。

相似文献

1
Synthesis of Phosphatidylserine and Its Stereoisomers: Their Role in Activation of Blood Coagulation.磷脂酰丝氨酸及其立体异构体的合成:它们在血液凝固激活中的作用。
ACS Med Chem Lett. 2018 Apr 12;9(5):434-439. doi: 10.1021/acsmedchemlett.8b00008. eCollection 2018 May 10.
2
Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.活化因子VII及活性位点抑制的活化因子VII与组织因子的相互作用。
Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S67-71.
3
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.活化因子VIII(FVIIIa)在凝血起始阶段FVIIa/组织因子依赖性FXa生成中的潜在作用。
Int J Hematol. 2019 Apr;109(4):390-401. doi: 10.1007/s12185-019-02611-3. Epub 2019 Feb 13.
4
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.高剂量凝血因子VIIa(FVIIa)在基于细胞的止血模型中的作用。
Dis Mon. 2003 Jan;49(1):14-21. doi: 10.1053/mda.2003.29504b.
5
Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.1型单纯疱疹病毒编码的糖蛋白C增强病毒上凝血因子VIIa的活性。
Thromb Haemost. 2004 Nov;92(5):947-55. doi: 10.1160/TH04-04-0242.
6
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.高剂量凝血因子VIIa(FVIIa)在基于细胞的止血模型中的作用。
Semin Hematol. 2001 Oct;38(4 Suppl 12):6-9. doi: 10.1016/s0037-1963(01)90140-4.
7
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.组织因子/因子VIIa/因子Xa复合物:通过对接和定点诱变构建的模型。
Proteins. 2003 Nov 15;53(3):640-8. doi: 10.1002/prot.10445.
8
Structural modulation of factor VIIa by full-length tissue factor (TF): implication of novel interactions between EGF2 domain and TF.全长组织因子(TF)对因子 VIIa 的结构调节:EGF2 结构域与 TF 之间新的相互作用的意义。
J Biomol Struct Dyn. 2018 Feb;36(3):621-633. doi: 10.1080/07391102.2017.1289125. Epub 2017 Feb 17.
9
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.磷脂酰乙醇胺增强因子VIIa-组织因子活性:增强对磷脂酰丝氨酸的敏感性。
Biochemistry. 1995 Oct 31;34(43):13988-93. doi: 10.1021/bi00043a004.
10
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma.关于合成五糖在人血浆凝固过程中对组织因子途径的抑制机制
Blood Coagul Fibrinolysis. 2003 Oct;14(7):633-8. doi: 10.1097/00001721-200310000-00003.

引用本文的文献

1
High-Quality Three-Dimensionally Cultured Cells Using Interfaces of Diblock Copolymers Containing Different Ratios of Zwitterionic -Oxides.使用含有不同比例两性氧化物的嵌段共聚物界面进行高质量的三维细胞培养。
ACS Appl Mater Interfaces. 2024 Aug 28;16(34):44575-44589. doi: 10.1021/acsami.4c10118. Epub 2024 Aug 19.
2
Design of Apoptotic Cell-Inspired Particles as a Blood Coagulation Test.设计受凋亡细胞启发的颗粒用于凝血测试。
Biomimetics (Basel). 2024 Jun 17;9(6):367. doi: 10.3390/biomimetics9060367.
3
Alcohol functionality in the fatty acid backbone of sphingomyelin guides the inhibition of blood coagulation.鞘磷脂脂肪酸主链中的醇官能团可抑制血液凝固。
RSC Adv. 2021 Jan 15;11(6):3390-3398. doi: 10.1039/d0ra09218e. eCollection 2021 Jan 14.
4
Synthesis of Phosphatidyl Glycerol Containing Unsymmetric Acyl Chains Using H-Phosphonate Methodology.采用 H-膦酸酯法合成含有不对称酰基链的磷脂甘油。
Molecules. 2022 Mar 28;27(7):2199. doi: 10.3390/molecules27072199.
5
Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs.脂肪酸链长驱动溶血磷脂酰丝氨酸依赖性免疫输出。
Cell Chem Biol. 2021 Aug 19;28(8):1169-1179.e6. doi: 10.1016/j.chembiol.2021.01.008. Epub 2021 Feb 10.
6
The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.溶血磷脂酰丝氨酸:一类新兴的信号溶血磷脂。
J Membr Biol. 2020 Oct;253(5):381-397. doi: 10.1007/s00232-020-00133-2. Epub 2020 Aug 7.
7
Stereospecific synthesis of phosphatidylglycerol using a cyanoethyl phosphoramidite precursor.使用氰乙基亚磷酰胺前体对磷脂酰甘油进行立体定向合成。
Chem Phys Lipids. 2020 Sep;231:104933. doi: 10.1016/j.chemphyslip.2020.104933. Epub 2020 Jun 11.
8
Role of Cell Surface Lipids and Thiol-Disulphide Exchange Pathways in Regulating the Encryption and Decryption of Tissue Factor.细胞表面脂质和巯基-二硫键交换途径在调控组织因子的加密和解密中的作用。
Thromb Haemost. 2019 Jun;119(6):860-870. doi: 10.1055/s-0039-1681102. Epub 2019 Mar 12.

本文引用的文献

1
Structural modulation of factor VIIa by full-length tissue factor (TF): implication of novel interactions between EGF2 domain and TF.全长组织因子(TF)对因子 VIIa 的结构调节:EGF2 结构域与 TF 之间新的相互作用的意义。
J Biomol Struct Dyn. 2018 Feb;36(3):621-633. doi: 10.1080/07391102.2017.1289125. Epub 2017 Feb 17.
2
Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.组织因子通过结构和动力学变化激活因子 VIIa 中的变构网络。
J Thromb Haemost. 2015 Feb;13(2):262-7. doi: 10.1111/jth.12791. Epub 2014 Dec 12.
3
Cloning, Expression, and Purification of Nucleoside Diphosphate Kinase from Acinetobacter baumannii.鲍曼不动杆菌核苷二磷酸激酶的克隆、表达及纯化
Enzyme Res. 2013;2013:597028. doi: 10.1155/2013/597028. Epub 2013 Apr 11.
4
Regulation of tissue factor coagulant activity on cell surfaces.组织因子促凝活性在细胞表面的调控。
J Thromb Haemost. 2012 Nov;10(11):2242-53. doi: 10.1111/jth.12003.
5
Oxidation of H-phosphonates with iodine by intramolecular support of a 2-pyridyl thermolabile protecting group.2-吡啶基内氢键热不稳定保护基促进 H-膦酸酯的碘氧化反应。
J Org Chem. 2012 Sep 21;77(18):7866-72. doi: 10.1021/jo300937k. Epub 2012 Sep 12.
6
Molecular determinants of phospholipid synergy in blood clotting.血液凝固中磷脂协同作用的分子决定因素。
J Biol Chem. 2011 Jul 1;286(26):23247-53. doi: 10.1074/jbc.M111.251769. Epub 2011 May 11.
7
Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.纤溶酶原激活物抑制剂-1 抑制与组织因子结合的因子 VIIa。
J Thromb Haemost. 2011 Mar;9(3):531-9. doi: 10.1111/j.1538-7836.2010.04167.x.
8
Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention.组织因子在心血管疾病病理生理学及药物干预中的作用
Adv Pharmacol. 2010;59:259-92. doi: 10.1016/S1054-3589(10)59009-4.
9
Synthesis of lysophospholipids.溶血磷脂的合成。
Molecules. 2010 Mar 8;15(3):1354-77. doi: 10.3390/molecules15031354.
10
Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative.溶血磷脂酰丝氨酸类似物作为肥大细胞脱颗粒诱导剂的合成与评价。溶血磷脂酰苏氨酸及其2-脱氧衍生物的强效活性。
J Med Chem. 2009 Oct 8;52(19):5837-63. doi: 10.1021/jm900598m.